Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivatives
US9717743B2 · kind B2 · utility
1Cited by
10References
51Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 12, 2014 |
| Grant date | Aug 1, 2017 |
| Priority date | — |
| Expiry date | Sep 12, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2121/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to pharmaceutical compositions comprising 4-pregenen-11β-17-21-triol-3,20-dione derivatives, and their use as pharmaceuticals as modulators of the glucocorticoid receptors (GR) and/or the mineralocorticoid receptors (MR). The invention relates specifically to the use of these compounds and their pharmaceutical compositions to treat ocular conditions associated with the glucocorticoid receptors (GR) and/or the mineralocorticoid receptors (MR).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.